Membrane permeabilizing peptides (MPPs) are as ubiquitous as the lipid bilayer
membranes they act upon. Produced by all forms of life, most membrane permeabilizing …

In recent decades, peptides, which can possess high potency, excellent selectivity, and low
toxicity, have emerged as promising therapeutics for cancer applications. Combined with an …

Several proteins and peptides have therapeutic potential and can be used for cancer
therapy. By binding to cell surface receptors and other indicators uniquely linked with or …

The major challenge in oral cancer is the lack of state‐of‐the‐art treatment modality that
effectively cures cancer while preserving oral functions. Recent insights into tumor metabolic …

Annexin A2 (ANXA2) is a calcium regulated phospholipid-binding protein. It is expressed in
some tumor cells, endothelial cells, macrophages, and mononuclear cells, affecting cell …

The tumor microenvironment in the majority of cancers is known to favor polarization of
tumor-associated macrophages (TAMs) to alternatively activated M2 phenotype, promoting …

Peptide-brush polymers (PBPs), wherein every side-chain of the polymers is peptidic,
represent a new class of proteomimetic with unusually high proteolytic resistance while …

Thanks to their wide range of biological activities, peptides have been extensively used to
afford designed materials with tailored properties. Peptides can be associated to polymers …

Gastric cancer is still a major cancer worldwide. The early diagnosis rate of gastric cancer in
most high incidence countries is low. At present, the overall treatment effect of gastric cancer …

Maintenance of bone homeostasis against diseased microenvironments remains as a major
challenge. Recently, mesenchymal stem cells (MSCs) have been unravelled as potent …